Origin Investment Corp I Units
NASDAQ:ORIQUShell Companies
+$0.51 today
- Market cap
- $67.93M
- Beta
- 0.06
- P/E (TTM)
- 75.4
- EPS (TTM)
- $0.14
Volume 0.00M
Average 0.00M
ORIQU EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Origin Investment Corp I UnitsNASDAQ: ORIQU
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$188.65K, compared with -$4.59K a year earlier. Trailing-twelve-month EBITDA was -$736.94K.
What to watch
Whether quarterly EBITDA holds near -$188.65K or moves back toward the trailing-twelve-month quarterly average of -$184.23K.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (678.17K) USD
- Year-over-year change
- —
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (678.17K) | — |
EBITDA vs competitors
How ORIQU compares with its peers on the latest reported figures
- ORIQU's LTM Mar 2026 EBITDA of -$736.94K is the 5th highest of the 8 companies compared; the peer median is -$484.33K.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $5.69M | +12.4% | +5.5% | 19.2% | |
HAVAUHarvard Ave Acquisition Corporation Unit | FY2025 | $0 | — | — | — |
| LTM Mar 2026 | -$248.91K | — | — | — | |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | -$484.33K | -135.0% | — | — |
ORIQUOrigin Investment Corp I Units | LTM Mar 2026 | -$736.94K | — | — | — |
EURKEureka Acquisition Corp Class A Ordinary Share | LTM Mar 2026 | -$1.06M | -74.4% | — | — |
QUMSUQuantumsphere Acquisition Corp. Units | LTM Mar 2026 | -$1.08M | — | — | — |
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares | LTM Mar 2026 | -$1.56M | — | — | — |
| Peer median (excluding ORIQU) | -$484.33K | -74.4% | +5.5% | 19.2% | |
Competitors are the stored peer set for ORIQU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 0 |
| Cost of Revenue | 0 |
| Gross Profit | 0 |
| Gross Margin | — |
| Research & Development | 0 |
| Selling, General & Admin | 678.17K |
| Operating Expenses | 678.17K |
| Depreciation & Amortization | 0 |
| EBITDA | (678.17K) |
| EBITDA Margin | — |
| Operating Income | (678.17K) |
| Operating Margin | — |
| Interest Income | 1.36M |
| Interest Expense | 0 |
| Other Income / Expenses | 1.36M |
| Income Before Tax | 683.1K |
| Pre-Tax Margin | — |
| Income Tax Expense | 0 |
| Net Income | 683.1K |
| Net Margin | — |
| EPS (Basic) | 0.13 |
| EPS (Diluted) | 0.13 |
| Weighted Avg Shares | 3.42M |
| Weighted Avg Shares (Diluted) | 3.42M |
Origin Investment Corp I Units
NASDAQ:ORIQU
Intrinsic Alpha fair value
Locked
Current Price
$10.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.